Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-04-15

Study Completion Date

2020-10-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As the detection of small pulmonary nodules continuously grows, the intraoperative localization of small pulmonary nodules is in great demand. The intraoperative localization nowadays is usually done under local anesthesia before surgery. There is a certain rate of failure and complication. The result of our early animal experiments show that the pulmonary surgery marker system can deliver the intraoperative localization safely and precisely under anesthesia, and the average distance between the localization and the simulated lesion is less than 5mm during surgery. Therefore, the safety and feasibility of the system require further evaluation in patients

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Efficacy of Intraoperative Pulmonary Nodules Localization Guided by Virtual Reality Technology

NCT04529603

Lung Neoplasm

WITHDRAWN NA

Comparing of Microcoil Localization and Hook Wire Localization for Resectable Pulmonary Small Nodules

NCT02908646

Thoracic Surgery

UNKNOWN PHASE3

Preoperative Computed Tomography-guided Localization for Lung Nodules: Localization Needle Versus Coil

NCT05183945

Lung; Node

UNKNOWN NA

Semi-barbed Suture for Pulmonary Small Nodules Localization

NCT04168359

Suture Nodule, Solitary Pulmonary Video-Assisted Thoracoscopic Surgery

COMPLETED NA

A Clinical Trial of Percutaneous Lung Ablation Using Navigational Positioning Robot-assisted Procedures

NCT07105813

Percutaneous Lung Ablation

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, single-center clinical trial initiated by the investigator. LungBrella marker can be accurately implanted into a predetermined position in the lung assisted by JediVision software and successfully marked the pulmonary nodules which needs to undergo Video-assisted thoracoscopic surgery. The study is expected to enroll 10 patients. Finally, the effectiveness and safety of the method will be evaluated. This method not only can complete pulmonary nodule localization in the operating room without occupying the resources of radiology department, but also can let patients receive pulmonary nodule location after anesthesia. Thereby the risks during transportation are avoided and the suffering of patients is reduced.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm A

LungBrella marker implanted into a predetermined position in the lung assisted by JediVision software and successfully marked the pulmonary nodules which needs to undergo Video-assisted thoracoscopic surgery

Group Type EXPERIMENTAL

LungBrella marker implantation and VATS partial lobe resection

Intervention Type DEVICE

The enrolled patients will receive a plain chest CT scan,then the data be loaded into JediVision software. The JediVision software can navigate the location of nodule and facilitate the implantation of LungBrella marker in the operating room after general anesthesia,then the patients will receive VATS partial lobe resection .

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LungBrella marker implantation and VATS partial lobe resection

The enrolled patients will receive a plain chest CT scan,then the data be loaded into JediVision software. The JediVision software can navigate the location of nodule and facilitate the implantation of LungBrella marker in the operating room after general anesthesia,then the patients will receive VATS partial lobe resection .

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Subjects should meet all of the following criteria

* diagnosis of pulmonary nodule, single nodule operation to be performed and nodule to be located by the decision of chief surgeon.
* commit to follow the research procedures and cooperate with the implementation of the whole process research
* 1 / 3 of pulmonary nodules are located in the periphery of the lung
* signed informed consent with date

Exclusion Criteria

* the target lesion is close to the hilar or large blood vessels
* subjects with FEV1 less than 1.2 in lung function
* subjects with cardiac function III and cardiac function IV (NYHA, New York)
* subjects with uncontrollable acute pleura infection
* patients with previous history of thoracic surgery (thoracotomy), plural infection, and plural thickening and adhesion on the affected side
* Other factors that investigators disagree enrollment.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No